ARCHIVES

Includes January Business & Regulatory Report (8-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 05 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

SEC Notifies ImClone It May Bring Action Against Company

June 21, 2002

Study Identifies Women Likely To Benefit From Therapy With Aromatase Inhibitors

November 24, 2006

AE-941 Shark Cartilage Doesn’t Improve Lung Cancer Survival

May 28, 2010

Rauscher Disappointed In CREG Progress

October 1, 1976

PHS Revises Lab Animal Policies

May 10, 1985

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003